Skip to main content
. 2021 Mar 20;2021:8878746. doi: 10.1155/2021/8878746

Table 4.

Clinical profile of pulmonary infections in diabetics and nondiabetics.

Variable Diabetics (n = 44) Nondiabetics (n = 53) p value
Symptoms
 Fever, n (%) 28 (63.6%) 47 (88.7%) 0.0032
 Cough, n (%) 32 (72.7%) 44 (83.0%) 0.22
 Expectoration, n (%) 21 (47.7%) 26 (49.1%) 0.90
 Chest pain, n (%) 5 (11.4%) 24 (45.3%) 0.0002
 Hemoptysis, n (%) 9 (20.5%) 24 (45.3%) 0.01
 Dyspnea, n (%) 26 (59.1%) 31 (58.5%) 0.88
 Conscious 36 (81.8%) 50 (94.4%) 0.053
 Unconscious 8 (18.2%) 3 (5.7%)
Associated comorbidities
 Heart failure, n (%) 3 (6.8%) 0 (0%) 0.021
 Renal failure, n (%) 7 (15.9%) 1 (1.9%)
 Chronic liver disease, n (%) 0 (0%) 1 (1.9%)
 None, n (%) 37 (84.1%) 51 (96.2%)
Systolic blood pressure, n (%)
 ≤90 mmHg 6 (13.6%) 2 (3.8%) 0.08
 >90 mmHg 38 (686.4%) 51 (96.2%)
Pulse rate, n (%)
 ≥100/min 19 (43.2%) 25 (47.2%) 0.69
 <100/min 25 (56.8%) 28 (52.8%)
Respiratory rate, n (%)
 ≥30/min 19 (43.2%) 21 (39.6%) 0.72
 <30/min 25 (56.8%) 32 (60.4%)
Temperature, n (%)
 <95°F 7 (15.9%) 1 (1.9%) 0.022
 94–104°F 36 (81.8%) 52 (98.1%)
 >104°F 1 (2.3%) 0 (0%)
TLC, n (%)
 ≥12,000 per cmm 20 (45.5%) 34 (64.2%) 0.064
 <12,000 per cmm 24 (54.5%) 19 (35.8%)
Serum sodium, n (%)
 <130 mEq/dL 13 (29.5%) 7 (13.2%) 0.047
 ≥130 mEq/dL 31 (70.5%) 46 (86.8%)
Blood urea, n (%)
 ≥60 mg/dL 8 (18.2%) 5 (9.4%) 0.2
 <60 mg/dL 36 (81.8%) 48 (90.6%)
Arterial pH, n (%)
 <7.35 20 (45.5%) 17 (32.1%) 0.18
 >7.35 24 (54.5%) 36 (67.9%)
pO2
 <60 mmHg 25 (56.8%) 51 (96.2%) <0.001
 ≤60 mmHg 19 (43.2%) 2 (3.8%)
PORT risk score (mean ± SD) 124.84 ± 41.31 77.85 ± 39.77 <0.001
Tubercular, n (%) 15 (34.1%) 21 (39.6%) 0.57
Nontubercular, n (%) 29 (65.9%) 32 (60.4%)
Sputum microscopy, n (%)
 AFB positive 9 (20.5%) 16 (30.2%) 0.50
 AFB negative 6 (13.6%) 5 (9.4%)
Mantoux test, n (%)
 Positive 8 (18.2%) 10 (18.9%) 0.99
 Negative 7 (15.9%) 10 (18.9%)

TLC: total leukocyte count; pO2: partial pressure of oxygen; AFB: acid-fast bacteria; PORT: pneumonia patient outcomes research team.